Get the Stockscreener App
8.88
1.00%
-0.09
Neuropace Inc stock is traded at $8.88, with a volume of 133.25K.
It is down -1.00% in the last 24 hours and down -1.11% over the past month.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
See More
Previous Close:
$8.97
Open:
$8.95
24h Volume:
133.25K
Relative Volume:
0.43
Market Cap:
$293.76M
Revenue:
$65.42M
Net Income/Loss:
$-32.96M
P/E Ratio:
-6.9921
EPS:
-1.27
Net Cash Flow:
$-19.87M
1W Performance:
+2.54%
1M Performance:
-1.11%
6M Performance:
-29.30%
1Y Performance:
+13.55%
1-Day Range:
$8.76
$8.98
1-Week Range:
$8.415
$9.17
52-Week Range:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Name
Neuropace Inc
Sector
Industry
Phone
(650) 237-2700
Address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Compare NPCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
8.88 | 296.74M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
131.46 | 229.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.87 | 157.64B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
393.15 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.05 | 118.26B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.90 | 47.71B | 5.69B | 1.41B | 577.90M | 6.95 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | H.C. Wainwright | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Mar-14-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Initiated | Leerink Partners | Outperform |
| Nov-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-24-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-22-23 | Initiated | Lake Street | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-19-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-11-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-18-21 | Initiated | Robert W. Baird | Outperform |
| May-17-21 | Initiated | JP Morgan | Overweight |
| May-17-21 | Initiated | Morgan Stanley | Overweight |
| May-17-21 | Initiated | SVB Leerink | Outperform |
| May-17-21 | Initiated | Wells Fargo | Overweight |
View All
Neuropace Inc Stock (NPCE) Latest News
How to monitor NeuroPace Inc. with trend dashboards2025 Bull vs Bear & Momentum Based Trading Signals - Newser
Price momentum metrics for NeuroPace Inc. explainedSwing Trade & Accurate Intraday Trading Signals - Newser
What MACD and RSI say about NeuroPace Inc.July 2025 Retail & Safe Capital Investment Plans - Newser
Building trade automation scripts for NeuroPace Inc.Trade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
How to use Fibonacci retracement on NeuroPace Inc.Trade Analysis Report & Expert Curated Trade Setup Alerts - Newser
Analyzing NeuroPace Inc. with risk reward ratio chartsBond Market & Daily Growth Stock Tips - Newser
Relative strength of NeuroPace Inc. in sector analysisQuarterly Growth Report & Daily Entry Point Alerts - Newser
Published on: 2025-08-27 07:52:16 - Newser
NeuroPace Inc. stock daily chart insights2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Applying chart zones and confluence areas to NeuroPace Inc.July 2025 Trends & Growth Oriented Trade Recommendations - Newser
Is NeuroPace Inc. stock reversal real or fake2025 Analyst Calls & Reliable Volume Spike Alerts - Newser
Should you hold or exit NeuroPace Inc. now2025 Fundamental Recap & AI Driven Stock Reports - Newser
NeuroPace Inc. Tests 50 Day MA After Sharp Decline getLinesFromResByArray error: size == 0 - 더경남뉴스
NeuroPace Inc. stock retracement – recovery analysisWeekly Trade Recap & Verified Technical Trade Signals - Newser
Can NeuroPace Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - kangso.co.kr
Applying sector rotation models to NeuroPace Inc.Market Movement Recap & Smart Investment Allocation Tips - Newser
Will NeuroPace Inc. stock recover after earningsRate Cut & Weekly Sector Rotation Insights - sundaytimes.kr
How hedge fund analytics apply to NeuroPace Inc. stock2025 Market Overview & Technical Pattern Based Signals - Newser
Using Bollinger Bands to evaluate NeuroPace Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser
Moving Average Crossover Confirms Uptrend in NeuroPace Inc.Exit Point & Growth-Oriented Investment Plans - beatles.ru
When is the best time to exit NeuroPace Inc.Trade Signal Summary & Weekly High Return Stock Forecasts - Newser
NeuroPace, Inc. (NASDAQ:NPCE) Receives $16.60 Consensus Target Price from Analysts - MarketBeat
Is a relief rally coming for NeuroPace Inc. holdersEntry Point & Verified Technical Trade Signals - Newser
Trading Action: Can NeuroPace Inc. sustain earnings growthJuly 2025 News Drivers & Fast Gain Stock Tips - theviewers.co.kr
What is HC Wainwright's Estimate for NeuroPace Q3 Earnings? - MarketBeat
NeuroPace Inc. Hits Oversold Level on RSI IndicatorWatch List & Stock Timing and Entry Methods - classian.co.kr
Neuropace (NPCE) Stock: A Bearish Crossroads of Technical and Fundamental Risks - AInvest
Leerink Partnrs Boosts Earnings Estimates for NeuroPace - MarketBeat
FY2029 EPS Estimates for NeuroPace Raised by Leerink Partnrs - MarketBeat
What is HC Wainwright's Forecast for NeuroPace Q1 Earnings? - MarketBeat
Lord Abbett & CO. LLC Takes Position in NeuroPace, Inc. $NPCE - MarketBeat
What risks could impact NeuroPace Inc. stock performanceWall Street Watch & Verified Momentum Stock Watchlist - Newser
Wells Fargo & Company Lowers NeuroPace (NASDAQ:NPCE) Price Target to $15.00 - MarketBeat
Deutsche Bank AG Has $11.36 Million Holdings in NeuroPace, Inc. $NPCE - MarketBeat
AI Trend Models Suggest Bounce for NeuroPace Inc.July 2025 Weekly Recap & High Accuracy Buy Signal Tips - newsimpact.co.kr
Q3 Earnings Estimate for NeuroPace Issued By HC Wainwright - Defense World
NeuroPace (NASDAQ:NPCE) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Will NeuroPace Inc. bounce back from current supportJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Is NeuroPace Inc. stock ready for a breakoutTrade Risk Assessment & Low Volatility Stock Recommendations - Newser
NeuroPace FY2025 EPS Estimate Boosted by Cantor Fitzgerald - MarketBeat
Why NeuroPace Inc. stock attracts strong analyst attentionPortfolio Performance Summary & Fast Moving Stock Trade Plans - Newser
Cantor Fitzgerald Boosts Earnings Estimates for NeuroPace - Defense World
What is HC Wainwright’s Forecast for NeuroPace Q1 Earnings? - Defense World
FY2025 EPS Estimates for NeuroPace Lifted by Leerink Partnrs - Defense World
Neuropace’s Innovative Approach to Treating Lennox-Gastaut Syndrome - MSN
Neuropace Inc Stock (NPCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):